토모큐브
475960KOSDAQ47.8 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Tomocube develops advanced cell imaging equipment, such as HT-2H and HT-X1, based on Holotomography (HT) technology, revolutionizing biomedical research and diagnostics. Widely adopted by over 200 institutions across 50+ countries, including MIT and ETH Zurich, the company is expanding into industrial applications, enhancing growth potential through semiconductor and display measurement devices.
Number of Employees
76people
Average Salary
55.2M KRW
Score Calculation Basis
Detailed Financial Score
8.2x industry avg (risky)
Well below industry avg
Half of industry avg (excellent)
Avg ▲90.4% (1-year basis)
Avg ▲36.6% (1-year basis)
Avg ROE -19.9% (improving, 2yr)
Detailed News Sentiment
- Positive이용관 대표 "논문 속 신기술을 돈 되는 사업으로 바꾸죠"
이용관 대표의 발언으로 토모큐브와 관련된 딥테크 기술의 상용화 가능성이 높아져 긍정적인 영향 예상.
- Neutral
- Positive“독자 기술로 저변 확대”…국내 현미경 기업 상반기 실적 순항
아이빔테크놀로지의 핵심 기술을 활용한 사업 확장으로 토모큐브와 유사한 현미경 기업의 상반기 실적이 긍정적으로 성장했다.
Detailed Momentum
Near 52w low (2%, downtrend)
1m -23.78% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral기업설명회(IR)개최2026-08-20
- Neutral반기보고서 (2026.06)2026-08-14
